Matthew Wolfe v. HHS - Meningococcal, Guillain-Barré Syndrome (2016)

Filed 2016-05-31Decided 2016-06-21Vaccine Meningococcal
compensated$106,000

Case summary [AI summaries can sometimes make mistakes]

On May 31, 2016, Stephanie Wolfe filed a petition on behalf of her then-minor son, Matthew Wolfe, alleging that the meningococcal vaccine administered on June 27, 2012, caused him to develop Guillain-Barré Syndrome (GBS). The respondent, the Secretary of Health and Human Services, denied that the vaccine caused Petitioner's GBS or any other injury.

The parties subsequently filed a joint stipulation on damages and attorneys' fees. The Special Master, Lisa Hamilton-Fieldman, found the stipulation to be reasonable and noted that the petition was brought in good faith with a reasonable basis for the claim.

The stipulation awarded Matthew Wolfe a lump sum of $85,000.00 for all damages, payable to Petitioner. Additionally, a lump sum of $21,000.00 was awarded for attorneys' fees and litigation costs, payable jointly to Petitioner and his counsel, Timothy J.

Carpuso, Esq. The court adopted the stipulation as its decision, and judgment was to be entered accordingly.

The case caption was later amended to reflect that Matthew Wolfe was no longer a minor. The public decision does not describe the specific onset of symptoms, medical tests, treatments, or the mechanism of causation.

Theory of causation

Petitioner Matthew Wolfe alleged that the meningococcal vaccine received on June 27, 2012, caused him to develop Guillain-Barré Syndrome (GBS). The respondent denied causation. The parties entered into a joint stipulation on damages and attorneys' fees, which was approved by Special Master Lisa Hamilton-Fieldman. The stipulation resulted in an award of $85,000.00 for all damages and $21,000.00 for attorneys' fees and costs. The public decision does not detail the specific theory of causation, medical experts, or the mechanism by which the vaccine allegedly caused GBS.

Source PDFs 1 total · 1 downloaded